2118 WALSH AVE., SUITE 210, SANTA CLARA, CA
HeartBeam, Inc. Enters $25 Million At-The-Market Equity Offering Agreement
Amended material disclosure
Shareholder votes
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition
Compensatory Arrangements Approved for President Branislav Vajdic
Announces Closing of $10 Million Public Offering of Common Stock
Other Events
Q2
Q1
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Statement of Changes in Beneficial Ownership
Free Writing Prospectus
Delisting Amendment
Submission Upload
Correspondence
Prospectus Filed Pursuant to Rule 424(b)(1)